Breast cancer is a type of malignancy in which abnormal breast cells grow uncontrollably and form tumours. These cells start inside the milk ducts or the milk-producing lobules of the breast. The earliest stage of this condition (in situ) is not life-threatening. However, if not detected, cancer can spread throughout the body and become fatal.
Though breast cancer is most commonly associated with women, it can also develop in men, as everyone has some breast tissue. However, the risk is significantly higher for females. According to the World Health Organisation, about 99% of breast cancer cases happen in women and only 0.5%-1% in men.
Breast cancer originates in specific types of cells within the breast tissue, primarily involving the following:
Ductal Cells: These cells line the milk duct within the breast. Cancer that starts in these cells is called ductal breast cancer or ductal carcinoma (the most common type of breast cancer).
Lobular Cells: They are cells in the lobules (milk-producing glands) of the breast. Cancer that starts in the lobules is called lobular breast cancer or lobular carcinoma.
Connective Tissue Cells: Cancer may rarely develop in connective tissue cells, which are found in the muscles, fat, and blood vessels. This type of breast cancer is known as soft tissue sarcoma.
Lymphatic System Cells: Very rarely, cancer, known as lymphoma, can start in the cells of the lymphatic system. This is mostly a type of non-Hodgkin lymphoma.
There are two broad categories of breast cancer, namely invasive and non-invasive. While some grow slowly, others are more aggressive. Various factors can affect the aggressiveness of a tumour, such as its size, stage, biological makeup, etc. Different types of breast cancer fall within these categories and include the following:
Non-invasive or in situ breast cancer cells do not spread beyond the breast tissue. There are two primary types of non-invasive breast cancers. These include the following:
1. Ductal Carcinoma In Situ (DCIS): Ductal carcinoma in situ, also known as intraductal carcinoma or stage 0 breast cancer, accounts for about one in every five new breast cancer cases. It begins as a mass in the milk duct and usually does not spread to other body parts.
However, sometimes, it can become an invasive cancer, spreading into nearby tissue and other body parts. With advancements in treatment, nearly all patients with this early stage of cancer can be cured.
2. Lobular Carcinoma In Situ (LCIS): Lobular carcinoma in situ is generally a benign breast condition that starts in the lobules and does not spread beyond it. It develops when cancer-resembling cells grow inside these lobules. However, people with LCIS have an increased risk of invasive breast cancer.
Invasive or infiltrating breast cancer means that cancer has spread to the surrounding breast tissue. Some common types of this malignancy include the following:
1. Invasive Ductal Carcinoma (IDC): This is the most common type of breast cancer, accounting for 80% of all cases. It starts in the milk duct (tubes that carry milk from the lobules to the nipple). Over time, the cancer cells can metastasise to other body parts. According to the American Cancer Society, two-thirds of women diagnosed with this type of cancer are 55 years or older.
Invasive ductal carcinoma has various rare subtypes, including:
Medullary Ductal Carcinoma: Individuals with this condition may feel an abnormally spongy area in the breast. According to a study by Martinez et al., it accounts for only 3% to 5% of breast cancers. 15
Mucinous Ductal Carcinoma: Also known as colloid breast cancer, this type develops when cancer cells in the milk duct produce mucous. The cancerous cells and mucous form a tumour. A study by Gupta et al. found its incidence to be approximately 1% to 7% of all breast cancer cases. 16
Papillary Carcinoma: While many papillary tumours are non-cancerous, even those that turn malignant are highly treatable. According to Johns Hopkins Medicine, this type of cancer is most common in people over 60. It forms papules (finger-like projections) that are visible under a microscope.
Tubular Ductal Carcinoma: According to NCBI, this rare type comprises only 1% to 2% of all breast cancers. 17 Under the microscope, it looks like hundreds of tiny tubules.
2. Invasive Lobular Carcinoma (ILC): The second most common type of breast cancer, invasive lobular carcinoma, accounts for about 10% of all invasive breast cancers. It begins in the milk-producing glands of the breast, also known as lobules.
3. Triple-Negative Breast Cancer (TNBC): It is a rare but aggressive form of cancer, accounting for about 10% to 15% of all breast cancer cases. This is different from other types of cancers as it does not contain the three most common receptors found in breast cancers. These include oestrogen, progesterone, and human epidermal growth factor receptor-2 (HER2) receptors. The condition is most common in women under 40.
4. Triple-Positive Breast Cancer (TPBC): About 10% of breast cancers are triple-positive. It develops when breast cancer cells have high levels of oestrogen, progesterone, and HER2 receptors. When hormones bind to their receptors, they instruct the cell to grow. An excess of HER2 proteins causes breast cells to grow and divide uncontrollably.
5. Inflammatory Breast Cancer (IBC): It is an aggressive type of cancer that makes up about 1% to 5% of all invasive breast cancers. The cancer cells in this condition block lymph vessels in the skin. Instead of a breast lump like in other types of breast cancer, it causes inflammatory symptoms, such as redness and swelling.
According to the American Cancer Society, about one in three cases are diagnosed when cancer has spread to distant parts of the body. As a result, the 5-year survival rate for inflammatory breast cancer is only 39%.
6. Metastatic Breast Cancer: Also known as stage 4 breast cancer, malignant cells metastasise (spread) to distant body parts like bones, lungs, liver, or brain. While some people are initially diagnosed with metastatic breast cancer, others may experience metastatic recurrence. It happens when breast cancer returns in another body part months or years after treatment.
7. Paget’s Disease of the Breast: Paget’s disease of the breast or nipple is a rare type of cancer that affects about 1% to 4% of people diagnosed with another breast cancer. It happens in the skin of the nipple and areola, forming tumour cells called Paget cells.
8. Angiosarcoma of the Breast: This type of breast cancer develops in the lining of lymph or blood vessels and constitutes 1% to 2% of all sarcomas. The condition is most common in people older than 70. It grows rapidly and usually goes undiagnosed until it spreads to other body parts.
9. Phyllodes Tumours of the Breast: These are rare tumours that begin in the connective tissue of the breast. However, most of these tumours are benign, and only 25% are malignant. While anyone can have these tumours, they mostly affect women in their 40s. Those with Li-Fraumeni syndrome (rare, hereditary syndrome) have a higher risk of the condition.
10. Medullary Breast Cancer: This rare, invasive cancer represents about 3% to 5% of all breast cancers. It begins in the milk ducts and spreads to the surrounding breast tissue. The tumour has a soft, fleshy appearance, resembling the soft grey matter of the brain stem (medulla). This type of cancer is most common in women in their late 40s and early 50s. Moreover, women with a mutation in the BRCA1 gene also have a higher risk of the condition.
Understanding the types of breast cancer is essential for choosing the right treatment and improving outcomes. Each type has distinct features that affect how it grows and responds to therapy. Early awareness can lead to timely interventions and more effective care.
HexaHealth is here to support you with expert guidance and personalised care. Whether you are looking for expert opinions or resources like types of breast cancer PPT, we will be with you every step of the way.
Various types of breast cancer start in the breast tissue. The four main types of this malignancy include the following:
Ductal carcinoma in situ
Invasive ductal carcinoma
Inflammatory breast cancer
Metastatic breast cancer
Invasive ductal carcinoma (IDC) is the most common type of breast cancer, which accounts for 80% of all breast cancer cases. These malignant cells begin in the milk ducts and spread to other parts of the body.
Yes, types of breast cancer images, such as illustrations, ultrasounds, and mammograms, are available to explain the differences in appearance and location within the breast. These images help in better understanding and diagnosis of the condition.
There are various rare types of breast cancer with unique characteristics that often require specialised treatment. These include:
Inflammatory breast cancer
Triple-negative breast cancer
Paget’s disease of the nipple
Phyllodes tumours
Medullary breast cancer
The stages of breast cancer range from 0 to IV, depending on tumour size, lymph node involvement, and cancer spread. While stage 0 is non-invasive, stage IV involves metastasis to distant body parts.
Breast cancer treatment depends on its type. Generally, it involves a combination of treatment options, including:
Surgery
Hormone therapy
Targeted therapy
The doctor selects a treatment based on the cancer’s characteristics and stage.
Non-invasive breast malignancy, such as ductal carcinoma in situ, stays within the milk ducts or lobules of the breast. On the other hand, invasive breast cancer, like invasive ductal carcinoma, spreads beyond these ducts or lobules into the surrounding breast tissue and other body parts.
Types of breast cancer images on mammograms, ultrasounds, and MRIs show distinct features. Non-invasive cancer often appears as calcifications or asymmetries. On the other hand, invasive types show a white patch or mass with irregular margins on the mammogram.
Different types of breast cancer tests are used to determine the size, stage, and treatment approach for breast cancer. These include:
Mammograms
Ultrasounds
MRIs
Biopsies
Lab tests like hormone receptor and HER2 status assessments
A mammogram is the most effective screening method for most women. It helps detect breast cancer in its early stages when treatment is easier. Other tests may include clinical breast exam (CBE) and magnetic resonance imaging (MRI).
Digital breast tomosynthesis (3D mammography) is a newer screening method that creates detailed, layered images of the breast. However, it is not yet known if it is better than standard mammography at identifying early-stage cancers and reducing false positives.
Triple-negative cancer is considered the most aggressive type of breast cancer. This is due to the following reasons:
It grows and spreads more rapidly than other types of cancers.
TNBC lacks hormone receptors, making it harder to treat with traditional hormone therapies.
Invasive breast cancers, especially invasive ductal carcinoma and triple-negative breast cancer, are most likely to metastasise. These cancer cells can spread to distant body parts like bones, lungs, liver, or brain.
Metastatic breast cancer, also called stage IV breast cancer, has the poorest prognosis due to its spread beyond the breast and lymph nodes. Cancer that reaches other body parts like the lungs, liver, or brain cannot be cured.
New treatments offer advanced options for specific types of breast cancer. These include:
Immunotherapy drugs like pembrolizumab (for some metastatic triple-negative cancer)
PI3 kinase inhibitors like alpelisib (for metastatic breast cancers)
Selective oestrogen receptor degraders like fulvestrant (for hormone receptor-positive metastatic cancers)
PARP inhibitors like olaparib (for HER2-negative metastatic cancer)
Note: Do not self-medicate. It is advised that you consult your doctor for personalised dosages of these drugs.
Breast cancer can be treated effectively, but recurrence is possible. Surgery, combined with therapies like radiation, chemotherapy, and hormonal treatments, aims for long-term remission. Regular follow-ups are essential for monitoring.
A breast cancer chemotherapy regimen usually includes 4 to 8 cycles, depending on the cancer’s type, stage, and patient response. The length of the cycle varies from weekly to every four weeks over 3 to 6 months.
All the articles on HexaHealth are supported by verified medically-recognized sources such as; peer-reviewed academic research papers, research institutions, and medical journals. Our medical reviewers also check references of the articles to prioritize accuracy and relevance. Refer to our detailed editorial policy for more information.
Last Updated on: 23 December 2024
Graduated & Post Graduated from Delhi University in Political Science.
3 Years Experience
As an SEO Content Writer with 3 years of experience, she specializes in creating high-quality, optimized content, including website content, blogs, articles and newsletters. Post-graduated in Political Science from...View More
Expert Doctors (10)
NABH Accredited Hospitals (7)
Latest Health Articles